Search Within

Mark Andrew Dickson

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (5)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (20)
  2. Sarcoma Service (20)
  3. Sloan Kettering Institute Postdocs (20)
  4. Solid Tumor Oncology Division (20)
  5. GSK Faculty (16)
  6. Tow Center for Developmental Oncology (TCDO) (16)

More Groups

People
  1. Samuel Singer (14)
  2. William Tap (14)
  3. Aimee Crago (9)
  4. Ciara Kelly (9)
  5. Cristina Antonescu (9)
  6. Mary Keohan (9)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (7)
  4. 2020 (2)
  5. 2019 (2)
  6. 2018 (3)

More Years

Publications
  1. Clinical Cancer Research (5)
  2. Journal of Clinical Oncology (4)
  3. Modern Pathology (2)
  4. Nature Communications (2)
  5. Cancer Research (1)
  6. JAMA Dermatology (1)

More Publications

Publishers
  1. American Association for Cancer Research (6)
  2. American Society of Clinical Oncology (6)
  3. Nature Publishing Group (3)
  4. Nature Research (2)
  5. American Medical Association (1)
  6. Impact Journals (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition
    Journal Article

    Chiang, S.; Vasudevaraja, V.; Serrano, J.; Stewart, C. J. R.; Oliva, E.; Momeni-Boroujeni, A.; Jungbluth, A. A.; Da Cruz Paula, A.; da Silva, E. M.; Weigelt, B.; more...
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Clinical outcome of leiomyosarcomas with somatic alteration in homologous recombination pathway genes
    Journal Article

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Qin, L. X.; Chi, P.; Dickson, M.; Gounder, M.; Kelly, C.; Keohan, M. L.; Nacev, B.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Rb and p53-deficient myxofibrosarcoma and undifferentiated pleomorphic sarcoma require Skp2 for survival
    Journal Article

    Li, G. Z.; Okada, T.; Kim, Y. M.; Agaram, N. P.; Sanchez-Vega, F.; Shen, Y.; Tsubokawa, N.; Rios, J.; Martin, A. S.; Dickson, M. A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • DNA damage response pathway alterations and clinical outcome in leiomyosarcoma
    Meeting Abstract

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Qin, L. X.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Imatinib treatment for locally advanced or metastatic dermatofibrosarcoma protuberans: A systematic review
    Review

    Navarrete-Dechent, C.; Mori, S.; Barker, C. A.; Dickson, M. A.; Nehal, K. S.
    JAMA Dermatology (2019)

    Fulltext@MSK | Save
  • PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence
    Journal Article

    Klein, M. E.; Dickson, M. A.; Antonescu, C.; Qin, L. X.; Dooley, S. J.; Barlas, A.; Manova, K.; Schwartz, G. K.; Crago, A. M.; Singer, S.; more...
    Oncogene (2018)

    Fulltext@MSK | Save
  • Kaposi’s sarcoma after autologous stem-cell transplantation and rituximab treatment
    Journal Article

    Geller, S.; Dickson, M. A.; Busam, K. J.; Myskowski, P. L.
    Journal of Oncology Practice (2018)

    Fulltext@MSK | Save
  • CDK4 inhibition and senescence: Pathway understanding leads to rational drug combinations
    Meeting Abstract

    Klein, M. E.; Kovatcheva, M.; Dickson, M. A.; Liu, D.; Crago, A. M.; Schwartz, G. K.; Tap, W. D.; Singer, S.; Koff, A.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • ATRX is a regulator of therapy induced senescence in human cells
    Journal Article

    Kovatcheva, M.; Liao, W.; Klein, M. E.; Robine, N.; Geiger, H.; Crago, A. M.; Dickson, M. A.; Tap, W. D.; Singer, S.; Koff, A.
    Nature Communications (2017)

    Fulltext@MSK | Save
  • MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition
    Journal Article

    Kovatcheva, M.; Liu, D. D.; Dickson, M. A.; Klein, M. E.; O'Connor, R.; Wilder, F. O.; Socci, N. D.; Tap, W. D.; Schwartz, G. K.; Singer, S.; more...
    Oncotarget (2015)

    Fulltext@MSK | Save